IGFBP7 and central nervous system cancer: As lower-grade glioma tissue sections do not express IGFBP7 (D Stanimirovic, unpublished observations), anti-IGFBP7 sdAb may feasibly represent a useful follow-up molecular imaging tool in determining when the ‘angiogenic switch’ has been turned on for low-grade gliomas.